Lantern Pharma LTRN Cash Flow Statement (2019-2026)

NASDAQ LTRN
$2.29 -0.20 (-8.03%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-2.48M-4.13M-7.06M-4.10M-4.51M-2.82M-6.15M-4.19M-5.94M-4.09M-4.63M-5.58M-5.45M-5.01M-5.79M-4.68M-4.54M-5.80M-4.17M-3.38M
Share-based Compensation (Quarter)
0.25M0.22M0.25M0.27M0.29M0.30M0.33M0.33M0.39M0.19M0.10M0.13M0.13M0.18M0.29M0.15M0.16M0.14M-0.37M0.26M
Gains from Investment Securities (Quarter)
0.14M0.07M0.05M
Asset Writedowns and Impairment (Quarter)
0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.05M0.05M0.04M0.02M
Cash from Operations (Quarter)
-1.73M-4.68M-2.04M-3.33M-2.73M-4.04M-2.67M-3.76M-3.59M-3.61M-3.39M-3.07M-5.19M-5.58M-3.97M-4.38M-3.94M-4.57M-2.79M-3.77M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.02M-0.01M
Depreciation & Amortization (CF) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Change in Working Capital
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)
0.51M-0.54M1.49M0.74M2.28M-2.14M-0.31M-0.07M0.18M-0.77M0.42M1.27M0.66M-1.03M0.74M-0.02M0.63M-0.81M0.47M-0.71M
Other Working Capital Changes (Quarter)
-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.05M-0.05M-0.05M-0.05M-0.04M-0.02M
Investing Activities
Capital Expenditures (Quarter)
0.00M1.000.01M0.01M0.01M0.00M0.01M0.00M0.00M0.00M0.00M0.00M555.001.00
Change in Acquisitions & Divestments (Quarter)
0.18M1.49M1.25M1.20M2.15M2.35M0.97M1.82M5.46M8.15M3.80M3.25M8.22M7.05M8.01M2.50M4.25M
Cash from Investing Activities (Quarter)
-1.00M-0.23M0.18M-0.53M-0.07M0.60M-0.96M-0.46M0.23M0.26M-0.56M-0.20M0.68M3.45M3.24M3.59M5.93M-1.70M4.25M
Financing Activities
Other financing activities (Quarter)
-1.000.07M0.30M0.05M0.01M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
0.69M0.89M1.00M1.08M0.92M1.27M
Net Equity Issued and Repurchased (Quarter)
0.30M0.03M0.67M
Misc.
Cash from Financing Activities (Quarter)
-1.00-0.87M-2.18M0.05M0.01M0.53M
Exchange Rate Effect (Quarter)
0.00M-0.03M0.01M0.01M-0.00M-0.01M-0.01M-0.00M-0.01M0.01M0.02M-0.07M0.00M0.03M-261.000.00M0.02M
Change in Cash (Quarter)
-20.02M-5.69M-3.14M-5.33M-3.29M-4.10M-2.06M-4.72M-4.06M-3.39M-3.63M-3.58M-5.38M-4.87M-0.59M-1.13M-0.32M2.33M-3.97M0.49M
Free Cash Flow (Quarter)
-1.73M-4.69M-2.04M-3.33M-2.73M-4.04M-2.68M-3.77M-3.59M-3.62M-3.39M-3.07M-5.19M-5.59M-3.97M-4.38M-3.94M-4.57M-2.79M-3.77M
Net Cash Flow (Quarter)
-1.73M-5.69M-3.15M-5.33M-3.26M-4.11M-2.07M-4.72M-4.05M-3.38M-3.13M-3.57M-5.39M-4.89M-0.52M-1.14M-0.34M1.36M-3.97M0.48M